Integral Derivatives’s Novartis NVS Stock Holding History

Integral Derivatives’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,156	Closed	-$764K	–	900
2017 Q4	$764K	Buy	10,156 +1,563	+18%	+$118K	0.02%	578
2017 Q3	$661K	Buy	8,593 +4,129	+92%	+$312K	0.01%	636
2017 Q2	$334K	Buy	+4,464	New	+$316K	0.01%	833
2015 Q3	–	Sell	-8,258	Closed	-$728K	–	1219
2015 Q2	$728K	Buy	+8,258	New	+$758K	0.02%	620
2015 Q1	–	Sell	-2,455	Closed	-$204K	–	1309
2014 Q4	$204K	Buy	+2,455	New	+$203K	﹤0.01%	1227
2014 Q1	–	Sell	-6,361	Closed	-$458K	–	1510
2013 Q4	$458K	Buy	+6,361	New	+$442K	0.01%	1072

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Integral Derivatives's NVS Position: Q3 2015 in Review

Integral Derivatives sold out of Novartis (NVS) in Q3 2015, closing a stake of 5,452 shares — an estimated $480K sold.

Integral Derivatives first reported a position in NVS in Q1 2015 and held it in 2 quarters. The position peaked at $570K in Q1 2015. 925 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Integral Derivatives reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
Integral Derivatives sold 5,452 Novartis shares in Q3 2015, an estimated $480K.
Integral Derivatives first reported a position in Novartis in Q1 2015 and held it in 2 quarters.
Integral Derivatives's Novartis position peaked at $570K in Q1 2015.
925 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Integral Derivatives's 13F filing for Q3 2015, filed 15 Oct 2015.